Timothy Rolph insider trades: Akero Therapeutics (AKRO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Timothy reports to the SEC
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | AKRO | ↓ Sell | 12,500 | $46.08 | $576K | Direct | Oct 9, 2025 (2d) |
| Sep 11, 2025 | AKRO | ↓ Sell | 553 | $43.02 | $24K | Direct | Sep 12, 2025 (1d) |
| Sep 8, 2025 | AKRO | ↓ Sell | 12,500 | $44.17 | $552K | Direct | Sep 10, 2025 (2d) |
| Aug 5, 2025 | AKRO | ↓ Sell | 12,500 | $49.30 | $616K | Direct | Aug 7, 2025 (2d) |
| Jul 7, 2025 | AKRO | ↓ Sell | 12,500 | $51.09 | $639K | Direct | Jul 9, 2025 (2d) |
| Jun 18, 2025 | AKRO | ↓ Sell | 1,129 | $54.84 | $62K | Direct | Jun 20, 2025 (2d) |
| Jun 10, 2025 | AKRO | ↓ Sell | 2,358 | $54.00 | $127K | Direct | Jun 12, 2025 (2d) |
| Jun 6, 2025 | AKRO | ↓ Sell | 37,500 | $54.52 | $2.0M | Direct | Jun 9, 2025 (3d) |
| May 6, 2025 | AKRO | ↓ Sell | 12,500 | $43.43 | $543K | Direct | May 8, 2025 (2d) |
| Apr 24, 2025 | AKRO | ↓ Sell | 6,250 | $41.03 | $256K | Direct | Apr 28, 2025 (4d) |
| Apr 7, 2025 | AKRO | ↓ Sell | 6,250 | $35.88 | $224K | Direct | Apr 10, 2025 (3d) |
| Mar 12, 2025 | AKRO | ↓ Sell | 516 | $44.88 | $23K | Direct | Mar 14, 2025 (2d) |
| Mar 5, 2025 | AKRO | ↓ Sell | 12,500 | $44.53 | $557K | Direct | Mar 7, 2025 (2d) |
| Feb 5, 2025 | AKRO | ↓ Sell | 18,750 | $56.51 | $1.1M | Direct | Feb 7, 2025 (2d) |
| Jan 27, 2025 | AKRO | ↓ Sell | 31,250 | $55.77 | $1.7M | Direct | Jan 29, 2025 (2d) |
| Dec 17, 2024 | AKRO | ↓ Sell | 3,800 | $31.10 | $118K | Direct | Dec 18, 2024 (1d) |
| Dec 10, 2024 | AKRO | ↓ Sell | 4,818 | $30.91 | $149K | Direct | Dec 12, 2024 (2d) |
| Sep 10, 2024 | AKRO | ↓ Sell | 537 | $26.18 | $14K | Direct | Sep 13, 2024 (3d) |
| Jun 11, 2024 | AKRO | ↓ Sell | 2,380 | $22.64 | $54K | Direct | Jun 13, 2024 (2d) |
| Mar 13, 2024 | AKRO | ↓ Sell | 619 | $28.33 | $18K | Direct | Mar 15, 2024 (2d) |
| Dec 14, 2023 | AKRO | ↓ Sell | 514 | $20.76 | $11K | Direct | Dec 18, 2023 (4d) |
| Sep 13, 2023 | AKRO | ↓ Sell | 531 | $50.34 | $27K | Direct | Sep 25, 2023 (12d) |
| Jun 16, 2023 | AKRO | ↓ Sell | 78,200 | $54.78 | $4.3M | Direct | Jun 21, 2023 (5d) |
| Jun 13, 2023 | AKRO | ↓ Sell | 509 | $55.16 | $28K | Direct | Jun 15, 2023 (2d) |
| Dec 29, 2022 | AKRO | ↓ Sell | 22,016 | $50.97 | $1.1M | Direct | Dec 30, 2022 (1d) |
| Nov 16, 2022 | AKRO | ↓ Sell | 7,085 | $45.28 | $321K | Direct | Nov 16, 2022 (0d) |
| Oct 26, 2022 | AKRO | ↓ Sell | 15,415 | $45.07 | $695K | Direct | Oct 27, 2022 (1d) |
| Oct 6, 2022 | AKRO | ↓ Sell | 22,500 | $39.29 | $884K | Direct | Oct 7, 2022 (1d) |
| Sep 30, 2022 | AKRO | ↓ Sell | 45,000 | $32.72 | $1.5M | Direct | Oct 4, 2022 (4d) |
| Sep 13, 2022 | AKRO | ↓ Sell | 22,500 | $29.18 | $657K | Direct | Sep 15, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Timothy Rolph's insider trades
Timothy Rolph is Chief Scientific Officer at Akero Therapeutics (AKRO). Since Sep 13, 2022, Timothy has reported no open-market purchases and 30 sales worth $18.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (20 filings), grants and awards (10 filings), gifts (3 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AKRO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.